<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37351002</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-0640</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in psychiatry</Title><ISOAbbreviation>Front Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Psychiatric consequences and issues of long COVID on patients with prior psychiatric comorbidities: a scoping review.</ArticleTitle><Pagination><StartPage>1181767</StartPage><MedlinePgn>1181767</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1181767</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpsyt.2023.1181767</ELocationID><Abstract><AbstractText>SARS-CoV-2 is a growing field of research and mental health in long COVID is one of its interesting domains. This scoping review aims at studying the outcomes of mental health in patients already known for psychiatric illness. This was done by researching the literature in two databases (Embase and PubMed) for articles studying mental health consequences of long COVID in patients already known for psychiatric history. Eleven studies were included. 6/11 studies found an effect of long COVID, with varying severity of outcomes studied, with either a worsening in length or severity. 4/11 did not find any correlation between worsening symptoms and psychiatric history. The methods for assessing which psychiatric symptoms to include and how to determine prior history were heterogeneous, making direct comparison sometimes difficult. The data seem to show worse effects of long COVID on mental health of patients with prior mental illness, with limitations regarding the heterogeneity of the studies' designs and focuses. It also highlights how neglected this population of patients is in the current state of research.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Hovagemyan, Dugerdil, Braggion, Mallet and Flahault.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hovagemyan</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dugerdil</LastName><ForeName>Adeline</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braggion</LastName><ForeName>Axelle</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallet</LastName><ForeName>Luc</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Mental Health and Psychiatry, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ Paris-Est Cr&#xe9;teil, DMU IMPACT, D&#xe9;partement M&#xe9;dical-Universitaire de Psychiatrie et d'Addictologie, H&#xf4;pitaux Universitaires Henri Mondor-Albert Chenevier, Assistance Publique-H&#xf4;pitaux de Paris, Cr&#xe9;teil, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flahault</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Psychiatry</MedlineTA><NlmUniqueID>101545006</NlmUniqueID><ISSNLinking>1664-0640</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mental health</Keyword><Keyword MajorTopicYN="N">psychiatric history</Keyword><Keyword MajorTopicYN="N">psychiatric symptoms</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>23</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>23</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>23</Day><Hour>10</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37351002</ArticleId><ArticleId IdType="pmc">PMC10282140</ArticleId><ArticleId IdType="doi">10.3389/fpsyt.2023.1181767</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen PJ, Pusica Y, Sohaei D, Prassas I, Diamandis EP. An overview of mental health during the COVID-19 pandemic. Diagnosis. (2021) 8:403&#x2013;12. doi: 10.1515/dx-2021-0046</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/dx-2021-0046</ArticleId><ArticleId IdType="pubmed">34214386</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwong ASF, Pearson RM, Adams MJ, Northstone K, Tilling K, Smith D, et al. . Mental health before and during the COVID-19 pandemic in two longitudinal UK population cohorts. Br J Psychiatry. (2020) 218:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7844173</ArticleId><ArticleId IdType="pubmed">33228822</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldrini M, Canoll PD, Klein RS. How COVID-19 affects the brain. JAMA Psychiat. (2021) 78:682&#x2013;3. doi: 10.1001/jamapsychiatry.2021.0500, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2021.0500</ArticleId><ArticleId IdType="pmc">PMC9894299</ArticleId><ArticleId IdType="pubmed">33769431</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum AW, Leo H, Ihle EC, Cooper J, Datta V. (PO-172) COVID-19 catatonia: a review and update after one year. J Acad Consult Liaison Psychiat. (2022) 63:S79. doi: 10.1016/j.jaclp.2022.03.164</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaclp.2022.03.164</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo M, Calisi D, De Rosa MA, Evangelista G, Consoli S, Dono F, et al. . COVID-19 and first manic episodes: a systematic review. Psychiatry Res. (2022) 314:114677. doi: 10.1016/j.psychres.2022.114677, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2022.114677</ArticleId><ArticleId IdType="pmc">PMC9181635</ArticleId><ArticleId IdType="pubmed">35716481</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasile CI, Vasile MC, Zlati ML, Herbei EE, Lep&#x103;datu L, Munteanu C, et al. . Post COVID-19 infection psychosis: could SARS-CoV-2 virus infection be a neuropsychiatric condition that triggers psychotic disorders?&#x2014;a case-based short review. Infect Drug Resist. (2022) 15:4697&#x2013;705. doi: 10.2147/IDR.S373578, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S373578</ArticleId><ArticleId IdType="pmc">PMC9416515</ArticleId><ArticleId IdType="pubmed">36034176</ArticleId></ArticleIdList></Reference><Reference><Citation>Ignatova D, Krasteva K, Akabalieva K, Alexiev S. Post-COVID-19 psychosis: Cotard&#x2019;s syndrome and potentially high risk of harm and self-harm in a first-onset acute and transient psychotic disorder after resolution of COVID-19 pneumonia. Early Interv Psychiatry. (2022) 16:1159&#x2013;62. doi: 10.1111/eip.13254, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eip.13254</ArticleId><ArticleId IdType="pmc">PMC8653068</ArticleId><ArticleId IdType="pubmed">34796667</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain MM, Tasnim S, Sultana A, Faizah F, Mazumder H, Zou L, et al. . Epidemiology of mental health problems in COVID-19: a review [internet]. F1000Res. (2020) 9:636. doi: 10.12688/f1000research.24457.1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.24457.1</ArticleId><ArticleId IdType="pmc">PMC7549174</ArticleId><ArticleId IdType="pubmed">33093946</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Sillett R, Zhu L, Mendel J, Camplisson I, Dercon Q, et al. . Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1&#x2008;284&#x2008;437 patients. Lancet Psychiatry. (2022) 9:815&#x2013;27. doi: 10.1016/S2215-0366(22)00260-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismael F, Bizario JCS, Battagin T, Zaramella B, Leal FE, Torales J, et al. . Post-infection depressive, anxiety and post-traumatic stress symptoms: a prospective cohort study in patients with mild COVID-19. Prog Neuro-Psychopharmacol Biol Psychiatry. (2021) 111:110341. doi: 10.1016/j.pnpbp.2021.110341, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2021.110341</ArticleId><ArticleId IdType="pmc">PMC8086265</ArticleId><ArticleId IdType="pubmed">33940097</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. . Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. (2022) 434:120162. doi: 10.1016/j.jns.2022.120162, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Giurgi-Oncu C, Tudoran C, Pop GN, Bredicean C, Pescariu SA, Giurgiuca A, et al. . Cardiovascular abnormalities and mental health difficulties result in a reduced quality of life in the post-acute COVID-19 syndrome. Brain Sci. (2021) 11:1456. doi: 10.3390/brainsci11111456, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11111456</ArticleId><ArticleId IdType="pmc">PMC8615893</ArticleId><ArticleId IdType="pubmed">34827455</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Post COVID-19 condition (long COVID) [internet]. (2023) Available at: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition (Accessed January 23, 2023).</Citation></Reference><Reference><Citation>Sivan M, Taylor S. NICE guideline on long covid. BMJ. (2020) 371:m4938. doi: 10.1136/bmj.m4938, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4938</ArticleId><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>Pai NM, Malyam V, Murugesan M, Ganjekar S, Moirangthem S, Desai G. Lithium toxicity at therapeutic doses as a fallout of COVID-19 infection: a case series and possible mechanisms. Int Clin Psychopharmacol. (2022) 37:25&#x2013;8. doi: 10.1097/YIC.0000000000000379, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/YIC.0000000000000379</ArticleId><ArticleId IdType="pmc">PMC8635074</ArticleId><ArticleId IdType="pubmed">34686643</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. . Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. (2020) 7:611&#x2013;27. doi: 10.1016/S2215-0366(20)30203-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong X, Zheng K, Tang M, Kong F, Zhou J, Diao L, et al. . Prevalence and factors associated with depression and anxiety of hospitalized patients with COVID-19. medRxiv [Preprint]. (2020) doi: 10.1101/2020.03.24.20043075v2</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.24.20043075v2</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R, O&#x2019;Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. (2008) 9:46&#x2013;56. doi: 10.1038/nrn2297, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2297</ArticleId><ArticleId IdType="pmc">PMC2919277</ArticleId><ArticleId IdType="pubmed">18073775</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. (2021) 372:n71. doi: 10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Efstathiou V, Stefanou MI, Demetriou M, Siafakas N, Makris M, Tsivgoulis G, et al. . Long COVID and neuropsychiatric manifestations (review). Exp Therap Med Mai. (2022) 23:363. doi: 10.3892/etm.2022.11290, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11290</ArticleId><ArticleId IdType="pmc">PMC9019760</ArticleId><ArticleId IdType="pubmed">35493431</ArticleId></ArticleIdList></Reference><Reference><Citation>Spaniel F, Bakstein E, Anyz J, Hlinka J, Sieger T, Hrdlicka J, et al. . Relapse in schizophrenia: definitively not a bolt from the blue. Neurosci Lett. (2018) 669:68&#x2013;74. doi: 10.1016/j.neulet.2016.04.044, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.04.044</ArticleId><ArticleId IdType="pubmed">27109788</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida OP. Prevention of depression in older age. Maturitas. (2014) 79:136&#x2013;41. doi: 10.1016/j.maturitas.2014.03.005, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2014.03.005</ArticleId><ArticleId IdType="pubmed">24713453</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoertel N, S&#xe1;nchez-Rico M, Vernet R, Beeker N, Jannot AS, Neuraz A, et al. . Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study. Mol Psychiatry. (2021) 26:5199&#x2013;212. doi: 10.1038/s41380-021-01021-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01021-4</ArticleId><ArticleId IdType="pubmed">33536545</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbody S, Littlewood E, Gascoyne S, McMillan D, Ekers D, Chew-Graham CA, et al. . Mitigating the impacts of COVID-19: where are the mental health trials? Lancet Psychiatry. (2021) 8:647&#x2013;50. doi: 10.1016/S2215-0366(21)00204-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00204-2</ArticleId><ArticleId IdType="pmc">PMC8169044</ArticleId><ArticleId IdType="pubmed">34087112</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Levis B, Sun Y, He C, Krishnan A, Neupane D, et al. . Accuracy of the hospital anxiety and depression scale depression subscale (HADS-D) to screen for major depression: systematic review and individual participant data meta-analysis. BMJ. (2021) 373:n972. doi: 10.1136/bmj.n972, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n972</ArticleId><ArticleId IdType="pmc">PMC8107836</ArticleId><ArticleId IdType="pubmed">33972268</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampogna G, Di Vincenzo M, Giallonardo V, Perris F, Volpicelli A, Del Vecchio V, et al. . The psychiatric consequences of long-COVID: a scoping review. J Personal Med. (2022) 12:1767. doi: 10.3390/jpm12111767, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12111767</ArticleId><ArticleId IdType="pmc">PMC9697474</ArticleId><ArticleId IdType="pubmed">36579511</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Zanardi R, Palladini M, Rovere-Querini P, Benedetti F. Rapid response to selective serotonin reuptake inhibitors in post-COVID depression. Eur Neuropsychopharmacol. (2022) 54:1&#x2013;6. doi: 10.1016/j.euroneuro.2021.09.009, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2021.09.009</ArticleId><ArticleId IdType="pmc">PMC8500775</ArticleId><ArticleId IdType="pubmed">34634679</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang JA, Chen WH, Liao NC, Wu CL, Fu YC, Chen PL. Acute delirium as an initial manifestation of COVID-19 patients with acute ischemic stroke: report on two cases. J Formos Med Assoc. (2022) 121:1605&#x2013;9. doi: 10.1016/j.jfma.2022.01.025, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2022.01.025</ArticleId><ArticleId IdType="pmc">PMC8841143</ArticleId><ArticleId IdType="pubmed">35221145</ArticleId></ArticleIdList></Reference><Reference><Citation>Burcusa SL, Iacono WG. Risk for recurrence in depression. Clin Psychol Rev. (2007) 27:959&#x2013;85. doi: 10.1016/j.cpr.2007.02.005, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpr.2007.02.005</ArticleId><ArticleId IdType="pmc">PMC2169519</ArticleId><ArticleId IdType="pubmed">17448579</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>